Skip to content
Back to Guavy Wire
Stocks

Windows Defender Ties Paid Antivirus Software in Malware Tests

Instruments
MSFT
Share

Paying for antivirus software has long been considered a necessity, but a recent study by independent labs has thrown this assumption into question. Between February and May 2026, AV-Comparatives ran 400 real-world attacks on various antivirus products, including Windows Defender.

The results showed that Microsoft Defender and Kaspersky were tied at the top with a 99.8% success rate, followed closely by Bitdefender with a 99.5% rate. However, what's more significant is that Defender recorded no false positives, while the paid options had five.

This finding suggests that Defender may be just as effective as its paid counterparts in protecting against malware, but at no cost to the user. The test also highlighted Microsoft Defender's reliance on cloud-based protection, which allows it to tap into Microsoft's live reputation and intelligence.

However, a closer look at the data reveals that Defender's local engine has a lower success rate when compared to other products. This raises questions about what exactly users are paying for with their antivirus subscriptions.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc